Quick Answer
ACRO BIOMEDICAL CO., LTD. reported Operating Income of -$154.0 thousand for fiscal year 2025.
ACRO BIOMEDICAL CO., LTD. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$154.0K | -305.8% |
| 2024 | -$38.0K | +99.6% |
| 2023 | -$8.80M | +44.5% |
| 2022 | -$15.87M | -106.3% |
| 2021 | -$7.69M | -5797.1% |
| 2020 | -$130.5K | +69.1% |
| 2019 | -$422.8K | +4.3% |
| 2019 | -$441.6K | -185.6% |
| 2018 | $515.5K | +23033.7% |
| 2017 | -$2.2K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$115.1K | -1164.0% | -745.4% |
| June 30, 2025 | -$13.6K | -49.8% | -52.4% |
| March 31, 2025 | -$8.9K | +13.2% | +1.9% |
| September 30, 2024 | -$9.1K | +99.4% | -0.2% |
| June 30, 2024 | -$9.1K | +99.7% | +11.8% |
| March 31, 2024 | -$10.3K | +99.7% | +99.4% |
| September 30, 2023 | -$1.59M | +60.4% | +50.3% |
| June 30, 2023 | -$3.19M | +20.1% | +20.2% |
- ACRO BIOMEDICAL CO., LTD. showed a decrease of -305.8% in Operating Income compared to the prior fiscal year.
- Over the 2017–2025 period, ACRO BIOMEDICAL CO., LTD.’s operating income has declined by 6751.6% (from -$2.2 thousand to -$154.0 thousand).
- The most recent figure is from ACRO BIOMEDICAL CO., LTD.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: